» Articles » PMID: 36168122

Design and Synthesis of Some New Benzoylthioureido Phenyl Derivatives Targeting Carbonic Anhydrase Enzymes

Overview
Specialty Biochemistry
Date 2022 Sep 28
PMID 36168122
Authors
Affiliations
Soon will be listed here.
Abstract

The present study aimed to develop potent carbonic anhydrase inhibitors (CAIs). The design of the target compounds was based on modifying the structure of the ureido-based carbonic anhydrase inhibitor SLC-0111. Six series of a substituted benzoylthioureido core were prepared featuring different zinc-binding groups; the conventional sulphamoyl group and , its bioisosteric carboxylic acid group and or the ethyl carboxylate group and as potential prodrugs. All compounds were assessed for their carbonic anhydrase (CA) inhibitory activity against a panel of four physiologically relevant human CA isoforms hCA I and hCA II, and hCA IX, and hCA XII. Compounds , , , , and revealed significant inhibitory activity against hCA I that would highlight these compounds as promising drug candidates for the treatment of glaucoma.

Citing Articles

Sulphonyl thiourea compounds containing pyrimidine as dual inhibitors of I, II, IX, and XII carbonic anhydrases and cancer cell lines: synthesis, characterization and studies.

Thanh N, Toan V, Trang V RSC Med Chem. 2025; .

PMID: 39823041 PMC: 11734695. DOI: 10.1039/d4md00816b.


Carbonic anhydrase inhibitory activity of phthalimide-capped benzene sulphonamide derivatives.

Shilkar D, Siddique M, Bua S, Yasmin S, Patil M, Timiri A J Enzyme Inhib Med Chem. 2023; 38(1):2235089.

PMID: 37439360 PMC: 10348020. DOI: 10.1080/14756366.2023.2235089.


Identification of specific carbonic anhydrase inhibitors click chemistry, phage-display and synthetic peptide libraries: comparison of the methods and structural study.

Kugler M, Hadzima M, Dzijak R, Rampmaier R, Srb P, Vrzal L RSC Med Chem. 2023; 14(1):144-153.

PMID: 36760748 PMC: 9890587. DOI: 10.1039/d2md00330a.


Investigation of novel alkyl/benzyl (4-sulphamoylphenyl)carbamimidothioates as carbonic anhydrase inhibitors.

Abdoli M, Bonardi A, Supuran C, Zalubovskis R J Enzyme Inhib Med Chem. 2023; 38(1):2152811.

PMID: 36629134 PMC: 9848269. DOI: 10.1080/14756366.2022.2152811.

References
1.
Elbadawi M, Eldehna W, Nocentini A, Abo-Ashour M, Elkaeed E, Abdelgawad M . Identification of N-phenyl-2-(phenylsulfonyl)acetamides/propanamides as new SLC-0111 analogues: Synthesis and evaluation of the carbonic anhydrase inhibitory activities. Eur J Med Chem. 2021; 218:113360. DOI: 10.1016/j.ejmech.2021.113360. View

2.
Angeli A, Carta F, Nocentini A, Winum J, Zalubovskis R, Akdemir A . Carbonic Anhydrase Inhibitors Targeting Metabolism and Tumor Microenvironment. Metabolites. 2020; 10(10). PMC: 7602163. DOI: 10.3390/metabo10100412. View

3.
Pacchiano F, Carta F, McDonald P, Lou Y, Vullo D, Scozzafava A . Ureido-substituted benzenesulfonamides potently inhibit carbonic anhydrase IX and show antimetastatic activity in a model of breast cancer metastasis. J Med Chem. 2011; 54(6):1896-902. DOI: 10.1021/jm101541x. View

4.
Ghorai S, Pulya S, Ghosh K, Panda P, Ghosh B, Gayen S . Structure-activity relationship of human carbonic anhydrase-II inhibitors: Detailed insight for future development as anti-glaucoma agents. Bioorg Chem. 2020; 95:103557. DOI: 10.1016/j.bioorg.2019.103557. View

5.
Mahdavi M, Shahzad Shirazi M, Taherkhani R, Saeedi M, Alipour E, Moghadam F . Synthesis, biological evaluation and docking study of 3-aroyl-1-(4-sulfamoylphenyl)thiourea derivatives as 15-lipoxygenase inhibitors. Eur J Med Chem. 2014; 82:308-13. DOI: 10.1016/j.ejmech.2014.05.054. View